Clinical and genetic analysis of a child with transcobalamin II deficiency.
10.3760/cma.j.cn511374-20200408-00247
- Author:
Chunlan YANG
1
;
Xiaodong WANG
;
Chunjing WANG
;
Xiaoling ZHANG
;
Yue LI
;
Yue YU
;
Sixi LIU
Author Information
1. Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong 518000, China. Tiger647@126.com.
- Publication Type:Journal Article
- MeSH:
Amino Acid Metabolism, Inborn Errors;
Child;
Female;
Genetic Testing;
Humans;
Rare Diseases;
Transcobalamins/genetics*;
Vitamin B 12
- From:
Chinese Journal of Medical Genetics
2021;38(10):993-996
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the genetic etiology, clinical diagnosis and treatment of a child with pancytopenia, failure to thrive and pulmonary infection.
METHODS:Peripheral blood samples of the child and her parents were collected. Genomic DNA was extracted. Genetic variants associated with hematological diseases were detected by high-throughput sequencing.
RESULTS:Three variants of TCN2 gene were found, one of which located in exon 5 upstream(c.581-8A>T), the parents has carried this variant; one in exon 6 (c.924_927del), the variant was originated from the mother; one in exon 7 (c.973C>T), the variant has ocurred de novo. The variants pathogenic analysis combined with clinical manifestation, pancytopenia, the increase in methylmalonic acid level and increased homocysteine, the child was diagnosed with transcobalaminIIdeficiency. The patient presented with respiratory infection, which was confirmed to be pneumocystosis by lung radioscopy and pathogenic high-throughput sequencing of broncho-alveolar lavage fluid. The patient presented with acute respiratory distress syndrome during the treatment with intramuscular injection of vitamin B
CONCLUSION:We reported a case of Chinese child with TCNII deficiency due to novel gene variant, and analyzed the pathogenicity of the three variants. The treatment of TCNII deficiency with cobalamin should be individualized.
